Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
Clinical trial NCT05426798 · UNKNOWN
Trial details
- NCT number
- NCT05426798
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2023-09-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.